Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Cardiac Valve Market Size And Revenue Outlook Through 2030
The cardiac valve market size has experienced significant growth in recent years. It is projected to expand from $12.41 billion in 2025 to $14.24 billion in 2026, achieving a compound annual growth rate (CAGR) of 14.8%. This growth during the historic period can be linked to a rising incidence of valvular heart diseases, the expansion of cardiac surgery programs, increased adoption of mechanical heart valves, advancements in surgical valve techniques, and improved availability of cardiac care facilities.
The cardiac valve market size is projected to experience substantial growth in the coming years. It is expected to expand to $24.02 billion by 2030, achieving a compound annual growth rate (CAGR) of 14.0%. This anticipated growth during the forecast period can be attributed to factors such as the increasing demand for transcatheter interventions, a rising focus on cardiac care for the elderly, the expansion of hybrid cardiac procedures, growing investments in next-generation valve technologies, and the increasing adoption of patient-specific valve solutions. Significant trends throughout the forecast period include the increasing adoption of transcatheter valve procedures, a rising demand for bioprosthetic heart valves, a growing preference for minimally invasive valve replacement, the expansion of advanced valve repair techniques, and an enhanced focus on valve durability and performance.
Get A Free Sample Report With In-Depth Market Insights:
Cardiac Valve Market Development Factors: What’s Supporting Demand?
An increasing occurrence of cardiovascular diseases is projected to drive the expansion of the cardiac valve market. The incidence of cardiovascular disease has progressively risen, attributed to elements like smoking, obesity, insufficient physical activity, and other burdens on the cardiovascular system. The main reason for coronary artery disease is the accumulation of fatty plaques in the arteries. These consistent increases in heart-related conditions have boosted the demand for cardiac valves to treat heart valve problems. For instance, in October 2024, as per the Centers for Disease Control, a US-based government agency, in 2023, approximately 919,032 people died from cardiovascular disease, accounting for 1 in every 3 deaths. Thus, the growing prevalence of cardiovascular diseases will fuel the growth of the cardiac valve market.
Cardiac Valve Market Segment Analysis Spotlighting Growth Areas
The cardiac valve market covered in this report is segmented –
1) By Type: Tissue Heart Valves, Transcatheter Heart Valves, Mechanical Heart Valves
2) By Position: Aortic Valve, Mitral Valve, Other Positions
3) By Treatment: Cardiac Valve Repair, Cardiac Valve Replacement
4) By End-Users: Hospital And Clinics, Specialty Centers, Cardiac Research Institute, Other End Users
Subsegments:
1) By Tissue Heart Valves: Bioprosthetic Valves (e.g., porcine, bovine), Homograft Valves
2) By Transcatheter Heart Valves: Transcatheter Aortic Valve Replacement (TAVR / TAVI) Valves, Transcatheter Mitral Valve Replacement (TMVR) Valves
3) By Mechanical Heart Valves: Tilting Disc Valves, Bileaflet Valves, Caged Ball Valves
Cardiac Valve Market Transformation Trends: What Innovations Are Driving Change?
Leading companies in the cardiac valve market are concentrating on developing technological advancements, such as transfemoral transcatheter mitral valve replacement (TMVR) systems, to cater to the increasing demand for minimally invasive therapies within an aging population experiencing rising rates of mitral regurgitation. A transfemoral TMVR system utilizes a collapsible frame and biologic valve leaflets that can be administered via a catheter through the femoral vein, thereby avoiding open-heart surgery and facilitating shorter recovery times, reduced procedural risk, and improved suitability for patients ineligible for surgery. For instance, in April 2025, Edwards Lifesciences, a U.S.-based medical device company, secured CE Mark approval for its SAPIEN M3 System, representing the first transcatheter mitral valve replacement therapy delivered using a transfemoral approach. The SAPIEN M3 combines a docking mechanism that first secures the native mitral leaflets and chordae by pulling them inward, creating a stable landing zone, followed by the deployment of a bioprosthetic valve; both components are delivered through a steerable 29 F guide sheath. This design permits precise placement, repositioning, and retrieval prior to final deployment, enhancing procedural safety and extending treatment possibilities to patients unsuitable for surgery or edge-to-edge repair.
Cardiac Valve Market Key Players Shaping Industry Direction
Major companies operating in the cardiac valve market are Abbott Laboratories, Edwards Lifesciences Corporation, Medtronic plc, Artivion Inc., Meril Life Sciences Pvt Ltd, Lepu Medical Technology Co Ltd, TTK Healthcare Limited, Braile Biomédica, JenaValve Technology Inc., Xeltis AG, Colibri Heart Valve LLC, On-X Life Technologies Inc., Thubrikar Aortic Valve Inc., LifeNet Health Inc., Auto Tissue Berlin GmbH, CryoLife Inc., LivaNova PLC, Foldax Inc., Micro Interventional Devices Inc., InnovHeart Srl
View The Full Cardiac Valve Market Report:
Cardiac Valve Market Regional Analysis: Which Geography Leads On Revenue?
North America was the largest region in the cardiac valve market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac valve market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
